Listen to “Trisomy 18, Edwards Syndrome Takes the Life or Baby Marita – Her Mom creates Marita Brings Life Foundation thin 2 ours with a max. Life…” on Spreaker.

Marita at 2 days old. We were told she was going to die within 2 ours with a max. Life expectancy of 2 days This was her at 2 days old, alive and kicking.

Where Do We Grieve?
when it is our safe place
that died.
How do we tell lungs
to breathe through the pain
when they’re mourning
the air itself. –
Bereaved mum, anonymous
Abstract
This research aims at examining parents’ healthcare experiences for children with Trisomy 13
and 18 across three countries in the EU and the US, with emphasis on cultural, social and
medical perspectives on their interaction with healthcare professionals. The study using
semi-structured interviews explores how parents and children are wronged systematically;
ways in which there can be a clear lack of communication, ethical dilemmas, and ways in
which children with Trisomy 13 and 18 are stereotyped regarding the treatment that they are
given. Going further into the principal outcomes, it is worth to note that the parents are
essential in demanding their childrens’ care, as they actively dispute the medical
professionals and fight for their children’s rights, if the latter face withdrawal of care, or even
active unconsented palliative care. Additionally, the research addresses how parents attempt
to strategize against these situations by forming parent support groups, both formally and
informally, that allow better access to better healthcare facilities. Moreover, there are the
further findings of the research – the research shows that there exist serious violations of
ethical principles such as the principle of informed consent, the criterion of proportionality
and human rights violations with regards to equal access of medical care for the disabled. The
research shows that there is a need to design and implement better and sensitive health care
practices that respect the views of families with T13/18. For example, it advocates for
increased understanding of profession and parent communication, increased support of family
members and more attention paid to discrimination against children with T13/18 in
healthcare. These findings advance the knowledge in the field of Medical Anthropology,
Disability Studies, and Genetic Counseling that can be useful in the future health care
practices and policies for the families of the children with genetic disorders.
Acknowledgements
This dissertation is dedicated to my daughter, Marita, who was born on July 31, 2018, and sadly passed away
on September 1, 2018. I may never know if she would have survived had she received the care typically afforded
to a child unaffected by a chromosomal anomaly. My daughter was denied even the most basic care, such as
water and food. I extend my deepest gratitude to those parents who have entrusted me with their stories and to
the children who have shared their profound joy and love for life with me. In particular, this dissertation is
especially dedicated to Febe, who tragically passed away, most likely unnecessarily, while I was in the process
of writing this dissertation. I also wish to thank everyone who supported me in various ways. Special thanks go
to Professor Jonathan Gross at DePaul University, Chicago, who never stopped believing in my work.
Preface
It’s January 25, 2018. I’m about to walk the dog, feeling good, when the phone rings and my obstetrician speaks
in an aggressive tone: “You haven’t looked up your NIPT (Non-Invasive Prenatal Testing) results!” I calmly
respond, “Yes, indeed,…” I try to explain that I decided not to look them up. Upon returning home, I felt I had
been somewhat pressured into this. She had said, “It’s good to test because you and your husband (“Who says I
am married?”, I remember thinking.), will be able to provide better care for your child in case it has a genetic
disorder like Down syndrome. You’re 38 years old, don’t you think it’s a good idea?” I had answered, “If this
test is meant to help me get better care for my baby… if I can use it to inform myself, and if it’s not going to be
used against me or my child or my family…I would like to do it.” Thus we proceeded.
“But will my child get better care?” I later wondered. “Why should I do a genetic test if any child is more than
welcome? Wasn’t I causing myself a lot of worries and difficulties by knowing, instead of enjoying the bliss of
not knowing? What would this knowledge and the accompanying stress do to my child?” The obstetrician told
me she wouldn’t look up the results, and I had trusted her. “It’s your own responsibility; I won’t do it for you,”
she said in a snarky tone, while handing me a post-it with a login and password. Today she calls me, seemingly
enraged, and I don’t get a chance to stop her. She interrupts me and continues shouting statistical facts through
the phone.
“Your child has a 43% chance of Edwards syndrome. It’s similar to Down syndrome but much worse. It comes
with curved legs and arms, rock-bottom feet,… It will never be able to walk or speak. It’s the worst possible
disability there is. When are you coming in?”
I sit down on the puppy’s crate. He keeps pulling at his leash, eager to go out, and doesn’t pay attention to my
phone conversation. Nature calls. I breathe deeply, trying to buy some time, and respond, “Why should I exactly
come in?” I notice a hint of irony in my voice—a tone I would later recognise in other parents’ voices, much
later, after my daughter had passed away and I finally connected with them.
The obstetrician sighs and exclaims, “YOU SHOULD COME IN FOR YOUR APPOINTMENT. THERE IS
NO TIME TO LOSE,” then continues, “You were already late,” this time in an accusatory tone. (“Being
pregnant is not being sick,” I remember thinking to myself. I was barely two months pregnant when I had
contacted her.) “Which appointment?” I ask. (“A 43% chance of Edwards syndrome?” What on earth does that
mean? “Is the baby going to be half disabled?”, I remember thinking while drifting away into cynicism.
Thoughts are racing through my head at this point.) Before I have a chance to ask for further clarifications, she
rambles on:
“…IN BELGIUM WE ABORT SUCH CHILDREN. YOU SHOULD COME IN FOR YOUR
APPOINTMENT!!”
I now understand what “your appointment” means when she explains her cultural understanding of the matter.
This was also my first encounter with a typical discursive practice around NIPT, abortion, and having a child
with a trisomy disorder. “Coming in for your appointment” clearly meant “in Belgium we abort such children”,
the “appointment” was the “abortion appointment,” and “aborting such children”, apparently a normal procedure
here.
Calmly and politely, I clarify my position: “Whether to abort my child or not is still a decision to be made by me
and me alone, in whichever country I live.” I am not necessarily pro-life, nor am I pro-abortion. However, I am a
feminist, and nobody decides over my body and the little foetus growing inside me but me.
My experience also has a personal component. Following the standard DSM definition, I could be seen as
disabled (cf. I am diagnosed on the autism spectrum). Yet, I strongly align with how autistic sociologist Judy
Singer described our neurological difference: we’re neurodivergent, not disabled. Strictly speaking, we’re not
even necessarily autistic in the negative sense of the word. I have other qualities, other capabilities. I know my
value, and I have equal rights. My future disabled child has equal rights too.
“My dog needs a walk. I’ll call you back later. Thank you so much for your call,” I manage to politely utter. As I
put down the phone, I feel an incredible sense of unsafety in and around my body. I tremble as I walk into the
woods behind the house. Walking through the forest, I listen to the sounds around me, while the dog happily
runs about. There seem to be no problems here… until I lose sight of him and find him standing on the ice of the
little lake. He’s looking at me with terrified eyes. I’m terrified too. What have I gotten myself into? We’re both
on thin ice… and I’ve made a huge mistake consenting with this NIPT.
While helping the dog out of his precarious situation, I somehow come to terms with what just happened. The
doctor, whom I had confided in, had literally pulled the rug out from under me. Weren’t these results supposed
to be used to “improve and provide better healthcare for my child in case she would have a genetic disorder?” I
wasn’t even thinking about how she had looked up my results while saying she wouldn’t. It didn’t sit well with
me that now, all of a sudden, “better healthcare” was being translated into a—supposedly, if I could believe
her—national procedure to abort “such children.” How trustworthy was this NIPT actually? I wanted to run, as
far away as I could. This wasn’t really happening… THIS WAS NOT GOING TO HAPPEN TO ME, TO
US… At that moment, I even thought I could escape from it.
I walked, almost ran back to the house. I felt so small, so vulnerable, so full of adrenaline… I’m back at the
house and call the hospital: “I am calling in reference to my earlier conversation with Dr. X, you might know
about it?” “Yes”, mumbles the nurse. “I am calling to say I am withdrawing consent in sharing my and my
daughter’s medical files with any other hospital, including my GP.” The nurse responded: “This is not how
things work over here, maybe it’s different in the Netherlands.” (I have a Dutch accent.) “Yes this is how things
work over here,” I respond firmly, “I live here. I was born and raised here and I am aware of my rights. I do have
a right to medical confidentiality as any other person does. This right applies to my and my child’s medical files.
Also in Belgium. So again, I am asking you to clearly include in my medical files and those of my child, that
there is no consent to share them with anyone. Also not my GP. Please can you make sure to have a copy
available? I’d like to pick it up as soon as possible. I’ll drop by in 30 minutes. If it’s not ready, I’ll wait.”
An hour later, files in hand, I find myself buying a newspaper in the city centre. I need something to ground
myself in reality. But while reading the newspaper, I can’t stop thinking: “This is not my world anymore.
Nothing in this newspaper relates to me. I am here, you are all there. I’m in a different world. I’m falling into an
abyss that you all don’t know about. What is happening to me…?” Then the phone rings. My GP: “I just had a
call and heard you picked up your files from the hospital?” “There is no consent to share my files.” At this point
I feel I am getting angry. My patience is gone. “Yes, I know,” she rambles on, but I am barely able to receive
what she says, and feel myself sinking away, deeper and deeper, until I hear: “But don’t you think that if the
doctor advises you to abort, it would be wise to listen to her? Don’t you think the doctor knows better?”
That afternoon, I contact my former GP in the Netherlands and politely ask for a referral to the nearest Dutch
hospital. I am Dutch, live on the Dutch-Belgian border, and am insured in both countries (a luxury not everyone
has). I firmly believe that crossing the border, I would find a welcoming and nurturing environment—a place
where my possibly disabled child would be treated as an equal citizen. If I had only known.
Introduction
This dissertation explores the experiences of families of children with Trisomy 13 and 18
(T13/18), two severe genetic disorders, within the healthcare systems of three countries in the
European Union (Belgium, the Netherlands and Germany), as compared to experiences of
parents in the American healthcare system. The research investigates the extent to which the
differing views of parents and physicians regarding the care of children with these genetic
disorders influences parents’ experiences when they encounter negative eugenics.
Additionally, the study seeks to identify the culturally specific strategies that families employ
in response to these challenges. The study will compare parental experiences in the healthcare
systems of the US, characterised by a typical litigiousness and overwhelming fear of being
sued for medical malpractice, and these three countries in the EU, in order to understand how
modern-day eugenics is constituted in both the prenatal and postnatal context in these
Western societies.
A key aspect in the disability debate is the evaluation of the role of medicine in
defining disability in Western societies. As Foucault (1976, p. 252) argues, in biopolitical
states, ‘medicine becomes a political intervention-technique with specific power-effects.
Medicine is a form of power-knowledge that can be applied to both the body and the
population’. Similarly, Oliver (1990, Ch. 3) contends that the category of ‘disability’ is
socially constructed and fluid, able to resolve systemic contradictions within a given society.
Moreover, once certain groups are classified within this category, it becomes difficult, if not
impossible, for them to be excluded, creating a ‘distributive dilemma’ for states that can be
addressed in different ways depending on their mode of production. Oliver (1990, Ch. 3)
suggests that distribution based on needs may indicate the emergence of a socialist system,
while distribution based on costs may reflect a capitalist mode of production.
As Foucault argues, in its most extreme forms this ‘distributive dilemma’ manifests in
biopolitical societies in forms of ‘racism’. Foucault (1976, p. 255-259) argues that ‘racism’,
is ‘primarily a way of introducing a break into the domain of life that is under powers’
control: the break between what must live and what must die’. According to him, racism may
be seen as processes of stigmatisation, abandonment, rejection, expulsion and discrimination,
on the one hand. Or, on the other hand, as processes of killing or indirect killing…

The post Trisomy 18, Edwards Syndrome Takes the Life or Baby Marita – Her Mom creates Marita Brings Life Foundation thin 2 ours with a max. Life expectancy of 2 days This was her at 2 days old, alive and kicking. appeared first on Good News!.

The post God’s Love, We Deliver Concert. appeared first on Good News!.

Here is the last thought from his book.

“And now, at the start of my seventh decade and after more than 13 years of endurance adventures that include successes I never thought possible, I find myself at a crossroads. I have stopped planning, beyond the World Majors. Instead, I will let my body and my desires at the time decide for me. What I know, though, is this: I want to always live a life of challenge and audacity in everything that I do. Eventually, age and presumably illness will take their toll and I will no doubt be forced to cede ground, but I will do so only reluctantly and hopefully with dignity. I will give age its due but not embrace it as an excuse to coast. Anything, or, more realistically, almost anything, is possible. Indeed, even the unlikeliest among us can become an Ironman.”
Jeffrey Weiss

Jeffrey is a successful business executive, an accomplished author of three books, and a two-time Ironman and an ultramarathoner. Jeffrey lives in Tel Aviv, where in 2024 he founded Stickers of Meaning, a project that preserves and educates about the memorial stickers that have appeared throughout Israel since October 7, 2023—honoring the fallen and inspiring the living with messages of love, purpose, daring, and joy.

The post Jeffrey Weiss, author of the award-winning memoir, Racing Against Time: On Ironman, Ultramarathons, and the Quest for Transformation in Mid-Life appeared first on Good News!.

New York, NY – February 24, 2026 – An evening of global recognition and humanitarian celebration will take place on Tuesday, February 24th, 2026 pa at 5:45 PM at 112 W. 27th Street, Manhattan, as Dr. Rami Gudovitch is honored with the distinguished Platinum Who’s Who Award at a United Nations–affiliated event hosted by an Accredited NGO MCIF.

Set against the backdrop of international leadership and humanitarian vision, the ceremony orchestrated by UN Ambassadors Monica Sanchez and Gloria Cressler will recognize Dr. Gudovitch’s unwavering commitment to uplifting humanity and inspiring meaningful global change. The Platinum Who’s Who Award is reserved for individuals whose leadership, compassion, and impact extend beyond borders — honoring those whose work embodies service, innovation, and a deep dedication to the betterment of society.

Dr. Gudovitch has become widely respected for his humanitarian initiatives and forward-thinking contributions that align with the United Nations’ mission of peace, cooperation, and sustainable global progress. His work reflects a powerful blend of professional excellence and heartfelt advocacy for communities in need.

The evening promises to bring together leaders, diplomats, philanthropists, and changemakers in celebration of those whose visions elevate humanity. With a theme centered on recognition and inspiration, the event underscores the importance of honoring individuals who transform challenges into opportunities for collective advancement.

“Celebrating those whose visions uplift humanity and inspire global change” serves as the guiding spirit of the ceremony — a message that perfectly reflects Dr. Gudovitch’s ongoing impact.

Media, dignitaries, and invited guests will gather to commemorate this milestone moment in Manhattan, shining a spotlight on leadership that transcends industries and borders.

For media inquiries or attendance information, please contact the event organizers.

Eileen Shapiro 631-506-6600 or email worldstarpublicrelations@gmail.com

The post Dr. Rami Gudovitch to Be Honored with Prestigious Platinum Who’s Who Award at United Nations–Affiliated Ceremony in Manhattan appeared first on Good News!.

#ReginaHarmon #FoodRecoveryNetwork

The post Regina Harmon, CEO Food Recovery Network shares how they manage this momentous task appeared first on Good News!.

For Immediate Release:  Dr. Lee is available for Interviews ASAP

New York, NY – The Knowledge Recovery Foundation Institute (KRFI) has been involved with a natural, botanical drug product derived from the bark of the Voacanga iboga plant , known as ibogaine. To date, numerous European organizations and Stanford University have reported the use of IBOGAINE WITH GREAT SUCCESS.

Myung Hi Sonserai Lee, the founder of KRFI, states, Public Benefit Corporation with 501(c)(3)  

We have been working on this for 40 years. We are excited to see New York pass a bipartisan bill, Senate Bill S1817, which requires the NYS Governor Hochul and Commissioner Cunningham of the NYS Office of Addiction Services and Supports (OASAS) to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment, opioid, and substance addiction.  Send your petition signature and a letter requesting NYS Governor Hochul and Commissioner Cunningham of the NYS Office of Addiction Services and Supports (OASAS) to sign the bill by January 2026, to meet the NYS Senate and Assembly deadline. Texas, California, and other states and countries are proceeding with research and legal implementation. www.krfi.org

Contact www.krfi.org/NYS Ibogaine Research Bill.  Write to Governor.Hochul@exec.ny.gov, and Senator Rodriguez for (BiPartisan Bill A6210 and S1817) Write to: Chinazo.Cunningham@OASES.ny.gov

KRFI is organizing a SUMMIT and New York Academy of Science on December 12, 2026.. Topics to be included:  www.krfi.org/NYS Ibogaine Research Bill petition. George Soros, Open Society Foundation for the Lifetime Humanitarian Award. NYS Attorney General Leticia James, Questors Best Human Rights Defense Award

Testimonials: Bryan Hubbard (Financial Times) – Economic Case for Recovery Investment: “ 

Americans for Ibogaine unites clinicians, researchers, and advocates to promote science-based awareness and reduce stigma around ibogaine therapy.

George Soros – Philanthropy & Global Mental Health Finance – The trust and support I have received over the years from individuals, organizations, and institutions like the Knowledge Recovery Institute serve as a foundation of credibility. Together, these relationships will continue to inspire confidence and foster unlimited growth in our shared mission to improve mental health worldwide.” George Soros, Open Society Foundation for the Lifetime Humanitarian Award.  NBA player Stéphane Lasme has stated· “Beyond physical trauma, players grapple with anxiety and identity loss after their careers end. Ibogaine has been a ‘game-changer’ for mental health, helping players find a new perspective and reconnect with themselves.” NBA player Lamar Odom discusses his ibogaine treatment; “he has recovered a sense of choice, even during tough life moments like losing his ‘best man’ (Kobe Bryant), Conor McGregor, MMA Champion, 11/25/25, “Ibogaine saved my life and family.”  

For Immediate Release:

New York, NY – The Knowledge Recovery Foundation Institute (KRFI) has been involved with a natural, botanical drug product derived from the bark of the Voacanga iboga plant *, known as ibogaine. To date, numerous European organizations and Stanford University have reported the use of IBOGAINE WITH GREAT SUCCESS.

Myung Hi Sonserai Lee, the founder of KRFI, states, * * 

We have been working on this for 40 years, and we are excited to see New York pass a bipartisan bill, Senate Bill S1817, which requires the NYS Governor Hochul and Commissioner Cunningham of the NYS Office of Addiction Services and Supports (OASAS) and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment, opioid, and substance addiction.  Send your petition signature and a letter requesting NYS Governor Hochul and Commissioner Cunningham of the NYS Office of Addiction Services and Supports (OASAS) to sign the bill by January 2026, to meet the NYS Senate and Assembly deadline. 

Contact www.krfi.org/NYS Ibogaine Research Bill.  Write to Governor.Hochul@exec.ny.gov, and Senator Rodriguez for (BiPartisan Bill A6210 and S1817) Write to: Chinazo.Cunningham@OASAS.ny.gov

KRFI looks forward to the Governor of New York implementing the bill, which could potentially save many people from addiction to opioids and Substance Use conditions for recovery.

KRFI is part of a private-public sector partnership consortium for Americans for Ibogaine that supports the Texas State Government in passing a bipartisan bill that allocated $ 50 million to ibogaine clinical trials.  KRFI, over the past 40 years, has developed Original Ibogaine extraction and formulation IPs with Access for Benefit Sharing of the IPs and the Royalty based private public sector partnership with Biodiversity + Carbon credits for partnering States/Countries that will immediately allow for U.S. trials to begin and is reaching out to a matching fund by Global Mental Health Security Fund for the NYS $300 million Ibogaine Clinical Research Bill.

Let’s bring everyone together to rally behind healing. Investors, wellness practitioners, advocates – Let’s help pass this bipartisan bill. To help proceed, here is a link for the supporting bill: Go to:  https://www.nysenate.gov/legislation/bills/2025/S1817

Additionally, KRFI is organizing a SUMMIT in New  York on December 11 and 12, 2026. Topics to be included:  www.krfi.org/NYS Ibogaine Research Bill petition

Support for Ibogaine has come from a private-public sector partnership, including grants and donations from the NYS Ibogaine Research Bill, as well as matching fund sponsors/investors, and consortium members for clinical trial alliances.

Bryan Hubbard (Financial Times) – Economic Case for Recovery Investment: “ 

Americans for Ibogaine unites clinicians, researchers, and advocates to promote science-based awareness and reduce stigma around ibogaine therapy. Through education, policy engagement, and community partnerships, we strive to expand safe and legal access to medically supervised care.”

George Soros – Philanthropy & Global Mental Health Finance

“I am deeply touched by your thoughtfulness and by the Questors: Global Mental Health Summit Committee’s recognition of my work in the field of mental health. Our work and actions have always been rooted in legality, transparency, and integrity. The truth will stand clear, revealing that my efforts have always been dedicated to the right cause and the greater good.    The trust and support I have received over the years from individuals, organizations, and institutions like the Knowledge Recovery Institute serve as a foundation of credibility. Together, these relationships will continue to inspire confidence and foster unlimited growth in our shared mission to improve mental health worldwide.”

NBA player Stéphane Lasme has stated· “Beyond physical trauma, players grapple with anxiety and identity loss after their careers end. Ibogaine has been a ‘game-changer’ for mental health, helping players find a new perspective and reconnect with themselves.”

NBA player Lamar Odom discusses his ibogaine treatment; “he has recovered a sense of choice, even during tough life moments like losing his ‘best man’ (Kobe Bryant), and in other situations that would have previously been triggers for him to return to drugs. “Just as fast as I say cocaine,” Lamar reflects, “the thought of it leaves my mind.” This interview is a testament to Odom’s recovery, which he attributes to ibogaine, to will, and to God, and serves as inspiration to others facing personal challenges. “Now I just wanna try to use my story to help people, because if I could get through that… I know they could; it shouldn’t take 12 strokes and 6 heart attacks for anybody else to get through it.”

Conor McGregor, MMA Champion, “ Ibogaine save my life and my family.” 11/25/2025.

Currently, active clinical trials are being conducted in Norway, Canada, and the UK. The Ibogaine Clinical Research Act is seeking a global alliance for the clinical trial and drug supply chain security through Access for Benefit Sharing – IP model.

* Iboga is a rainforest perennial shrub (Voacanga iboga), from which IBOGAINE is derived, native to Central Africa. A member of the Apocynaceae family, indigenous to Gabon, the Democratic Republic of the Congo, and the Republic of the Congo, it is cultivated across Central Africa for its medicinal and other effects.  KRFI has identified central and South American cultivars for indigenous collective production under Access for Benefit Sharing and IP registration for the local PPP framework, and In-country coordination for the Ministry of Health Mental Health Program and UNCED.

** We request that the New York State Senate and Assembly introduce and pass a bipartisan bill authorizing by January 2026:
– Allocation of NYS  $12 Bn Opioid Settlement Funds for OASIS Commission for Opioid Abatement for FDA-approved Ibogaine trials “An Ibogaine Clinical Research Bill”
– Establishment of the Mental Health Security Hyperledger Security (1) Access for Benefit Sharing – Intellectual Property Rights (ABS-IP) for a PPP framework for secure clinical and supply chain data on the hyperledger dashboard

– State adoption of the Natural Medicine Health Act for plant-based treatment research and veterans and indigenous tribes for health equity by the In-state Clinical Trial Management and Reporting  partnership (CTMS-Reporting) for the first responders and practitioner training for pharmacovigilance (Drug – Drug interactions affecting our society) on entheogenic ibogaine and psychedelics 

This bill would create a legal and financial framework for New York to lead national policy on breakthrough addiction treatments.

Background for KRFI 

Join Us at the Global Mental Health Summit on December 12, 2025, at the New York Academy of Medicine.  December 12th, 2025, Gala Award Ceremony Dinner honoring George Soros, Open Society Foundation for the Lifetime Humanitarian Award. NYS Attorney General Leticia James, Questors Best Human Rights Defense Award

The Knowledge Recovery Foundation Institute is a Public Benefit Corporation with 501(c)(3) nonprofit status in advancing global addiction recovery research through clinical, technological, and policy innovation. KRFI leads the Global Mental Health Security Fund initiative to accelerate equitable access to psychedelic-assisted therapies and ensure international collaboration through Access & Benefit Sharing (ABS) models.

All Charitable donations for Knowledge Recovery Institute, a 501(c)(3) tax-exempt public charity – Tax ID# 73-3223951. All Contributions are tax-deductible to the extent allowable by law.

Note:  IBOGAINE is not FDA-approved, and it is guided under Medically Assisted Therapy under regulatory compliance. Not all patients can use IBOGAINE, so speak to your doctor about it for future use.

For More Information contact: Info@krfi.org; KRFI PR & Media: paul.sladkus@Krfi.org; 212 647 1212 and/or KRFI Questors Private Public Sector Partnership: andres.cordova@krfi.org 214-725-7088

Donate@krfi.org and Schedule a meeting with PPP membership: Membership@krfi.org

To watch the PSA, go to: https://www.krfi.org/psa

KRFI will also be a supporter of the Times Square Earth Day concert on April 22, 2026.  www.pausetheworldforpeace.org

The post Emergency – A New Organic BOTANICAL MEDICINE “Short Recovery” Solution to Drug Addiction is Here appeared first on Good News!.

The post Dr. David Weill, author of TELL ME I BELONG: A Journey Across Faiths and Generations (Union Square & Co.; December 9, 2025) appeared first on Good News!.

At St. Peter’s Chelsea in Manhattan, volunteers lined up cans of food for distribution to the public.  Credit…Marco Postigo Storel for The New York Times

The post Houses of Worship Struggle to Feed New Yorkers During SNAP Stalemate appeared first on Good News!.

The post 7 Powerful Plant Proteins That Pack a Punch – Earth Day appeared first on Good News!.

Listen to “Thank GOD Amorino Gelato is NOT Out of this WORLD!! Special Re-opening” on Spreaker.

Reverend Paul Sladkus All Faiths and Spiritual
Founder, Producer, Host
www.pausetheworldforpeace.org
www.youtube.com/goodnewsbroadcast

The post Thank GOD Amorino Gelato is NOT Out of this WORLD!! Special Re-opening appeared first on Good News!.